Long Noncoding RNA MEG3 Is an Epigenetic Determinant of Oncogenic Signaling in Functional Pancreatic Neuroendocrine Tumor Cells

REFERENCES

• Trusolino L, Bertotti A, Comoglio PM. 2010. MET signalling: principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol 11:834–848. https://doi.org/10.1038/nrm3012.
   PubMed Web of Science ®Google Scholar
• Cooper CS, Park M, Blair DG, Tainsky MA, Huebner K, Croce CM, Vande Woude GF. 1984. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 311:29–33. https://doi.org/10.1038/311029a0.
   PubMed Web of Science ®Google Scholar
• Maroun CR, Rowlands T. 2014. The Met receptor tyrosine kinase: a key player in oncogenesis and drug resistance. Pharmacol Ther 142:316–338. https://doi.org/10.1016/j.pharmthera.2013.12.014.
   PubMed Web of Science ®Google Scholar
• Cui JJ. 2014. A new challenging and promising era of tyrosine kinase inhibitors. ACS Med Chem Lett 5:272–274. https://doi.org/10.1021/ml500091p.
   PubMedGoogle Scholar
• Hansel DE, Rahman A, House M, Ashfaq R, Berg K, Yeo CJ, Maitra A. 2004. Met proto-oncogene and insulin-like growth factor binding protein 3 overexpression correlates with metastatic ability in well-differentiated pancreatic endocrine neoplasms. Clin Cancer Res 10:6152–6158. https://doi.org/10.1158/1078-0432.CCR-04-0285.
   PubMed Web of Science ®Google Scholar
• Krampitz GW, George BM, Willingham SB, Volkmer JP, Weiskopf K, Jahchan N, Newman AM, Sahoo D, Zemek AJ, Yanovsky RL, Nguyen JK, Schnorr PJ, Mazur PK, Sage J, Longacre TA, Visser BC, Poultsides GA, Norton JA, Weissman IL. 2016. Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors. Proc Natl Acad Sci U S A 113:4464–4469. https://doi.org/10.1073/pnas.1600007113.
   PubMed Web of Science ®Google Scholar
• Modali SD, Parekh VI, Kebebew E, Agarwal SK. 2015. Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors. Mol Endocrinol 29:224–237. https://doi.org/10.1210/me.2014-1304.
   PubMedGoogle Scholar
• Murat Cde B, da Rosa PW, Fortes MA, Correa L, Machado MC, Novak EM, Siqueira SA, Pereira MA, Correa-Giannella ML, Giannella-Neto D, Giorgi RR. 2015. Differential expression of genes encoding proteins of the HGF/MET system in insulinomas. Diabetol Metab Syndr 7:84. https://doi.org/10.1186/s13098-015-0079-3.
   PubMedGoogle Scholar
• Halfdanarson TR, Rabe KG, Rubin J, Petersen GM. 2008. Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol 19:1727–1733. https://doi.org/10.1093/annonc/mdn351.
   PubMed Web of Science ®Google Scholar
• Yao JC, Eisner MP, Leary C, Dagohoy C, Phan A, Rashid A, Hassan M, Evans DB. 2007. Population-based study of islet cell carcinoma. Ann Surg Oncol 14:3492–3500. https://doi.org/10.1245/s10434-007-9566-6.
   PubMed Web of Science ®Google Scholar
• Zhang J, Francois R, Iyer R, Seshadri M, Zajac-Kaye M, Hochwald SN. 2013. Current understanding of the molecular biology of pancreatic neuroendocrine tumors. J Natl Cancer Inst 105:1005–1017. https://doi.org/10.1093/jnci/djt135.
   PubMedGoogle Scholar
• Norton JA, Krampitz G, Jensen RT. 2015. Multiple endocrine neoplasia: genetics and clinical management. Surg Oncol Clin N Am 24:795–832. https://doi.org/10.1016/j.soc.2015.06.008.
   PubMed Web of Science ®Google Scholar
• Agarwal SK. 2017. Molecular genetics of MEN1-related neuroendocrine tumors, p 47–64. InPacak K, Taïeb D (ed), Diagnostic and therapeutic nuclear medicine for neuroendocrine tumors. Springer International Publishing, Cham, Switzerland.
   Google Scholar
• Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML, Endocrine S. 2012. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97:2990–3011. https://doi.org/10.1210/jc.2012-1230.
   PubMed Web of Science ®Google Scholar
• Shin JJ, Gorden P, Libutti SK. 2010. Insulinoma: pathophysiology, localization and management. Future Oncol 6:229–237. https://doi.org/10.2217/fon.09.165.
   PubMed Web of Science ®Google Scholar
• Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL, Marx SJ. 1997. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276:404–407. https://doi.org/10.1126/science.276.5311.404.
   PubMed Web of Science ®Google Scholar
• Lemmens I, Van de Ven WJ, Kas K, Zhang CX, Giraud S, Wautot V, Buisson N, De Witte K, Salandre J, Lenoir G, Pugeat M, Calender A, Parente F, Quincey D, Gaudray P, De Wit MJ, Lips CJ, Hoppener JW, Khodaei S, Grant AL, Weber G, Kytola S, Teh BT, Farnebo F, Thakker RV, et al.. 1997. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Hum Mol Genet 6:1177–1183. https://doi.org/10.1093/hmg/6.7.1177.
   PubMed Web of Science ®Google Scholar
• Lemmens I, Merregaert J, Van de Ven WJ, Kas K, Zhang CX, Giraud S, Wautot V, Buisson N, De Witte K, Salandre J, Lenoir G, Calender A, Parente F, Quincey D, Courseaux A, Carle GF, Gaudray P, De Wit MJ, Lips CJ, Hoppener JW, Khodaei S, Grant AL, Weber G, Kytola S, Thakker RV, et al.. 1997. Construction of a 1.2-Mb sequence-ready contig of chromosome 11q13 encompassing the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Genomics 44:94–100.
   PubMedGoogle Scholar
• Agarwal SK. 2013. Multiple endocrine neoplasia type 1. Front Horm Res 41:1–15. https://doi.org/10.1159/000345666.
   PubMedGoogle Scholar
• Cao Y, Gao Z, Li L, Jiang X, Shan A, Cai J, Peng Y, Li Y, Jiang X, Huang X, Wang J, Wei Q, Qin G, Zhao J, Jin X, Liu L, Li Y, Wang W, Wang J, Ning G. 2013. Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1. Nat Commun 4:2810. https://doi.org/10.1038/ncomms3810.
   PubMedGoogle Scholar
• Cromer MK, Choi M, Nelson-Williams C, Fonseca AL, Kunstman JW, Korah RM, Overton JD, Mane S, Kenney B, Malchoff CD, Stalberg P, Akerstrom G, Westin G, Hellman P, Carling T, Bjorklund P, Lifton RP. 2015. Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in insulin-producing adenomas. Proc Natl Acad Sci U S A 112:4062–4067. https://doi.org/10.1073/pnas.1503696112.
   PubMedGoogle Scholar
• Jiao Y, Shi C, Edil BH, de Wilde RF, Klimstra DS, Maitra A, Schulick RD, Tang LH, Wolfgang CL, Choti MA, Velculescu VE, Diaz LA, Jr, Vogelstein B, Kinzler KW, Hruban RH, Papadopoulos N. 2011. DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 331:1199–1203. https://doi.org/10.1126/science.1200609.
   PubMed Web of Science ®Google Scholar
• Lichtenauer UD, Di Dalmazi G, Slater EP, Wieland T, Kuebart A, Schmittfull A, Schwarzmayr T, Diener S, Wiese D, Thasler WE, Reincke M, Meitinger T, Schott M, Fassnacht M, Bartsch DK, Strom TM, Beuschlein F. 2015. Frequency and clinical correlates of somatic Ying Yang 1 mutations in sporadic insulinomas. J Clin Endocrinol Metab 100:E776–E782. https://doi.org/10.1210/jc.2015-1100.
   PubMedGoogle Scholar
• Scarpa A, Chang DK, Nones K, Corbo V, Patch AM, Bailey P, Lawlor RT, Johns AL, Miller DK, Mafficini A, Rusev B, Scardoni M, Antonello D, Barbi S, Sikora KO, Cingarlini S, Vicentini C, McKay S, Quinn MC, Bruxner TJ, Christ AN, Harliwong I, Idrisoglu S, McLean S, Nourse C, Nourbakhsh E, Wilson PJ, Anderson MJ, Fink JL, Newell F, Waddell N, Holmes O, Kazakoff SH, Leonard C, Wood S, Xu Q, Nagaraj SH, Amato E, Dalai I, Bersani S, Cataldo I, Dei Tos AP, Capelli P, Davi MV, Landoni L, Malpaga A, Miotto M, Whitehall VL, Leggett BA, Harris JL, et al.. 2017. Whole-genome landscape of pancreatic neuroendocrine tumours. Nature 543:65–71. https://doi.org/10.1038/nature21063.
   PubMed Web of Science ®Google Scholar
• Agarwal SK. 2014. Exploring the tumors of multiple endocrine neoplasia type 1 in mouse models for basic and preclinical studies. Int J Endocr Oncol 1:153–161. https://doi.org/10.2217/ije.14.16.
   PubMedGoogle Scholar
• Piret SE, Thakker RV. 2011. Mouse models for inherited endocrine and metabolic disorders. J Endocrinol 211:211–230. https://doi.org/10.1530/JOE-11-0193.
   PubMedGoogle Scholar
• Agarwal SK, Jothi R. 2012. Genome-wide characterization of menin-dependent H3K4me3 reveals a specific role for menin in the regulation of genes implicated in MEN1-like tumors. PLoS One 7:e37952. https://doi.org/10.1371/journal.pone.0037952.
   Google Scholar
• Assie G, Jouinot A, Bertherat J. 2014. The ‘omics’ of adrenocortical tumours for personalized medicine. Nat Rev Endocrinol 10:215–228. https://doi.org/10.1038/nrendo.2013.272.
   PubMedGoogle Scholar
• Braconi C, Kogure T, Valeri N, Huang N, Nuovo G, Costinean S, Negrini M, Miotto E, Croce CM, Patel T. 2011. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 30:4750–4756. https://doi.org/10.1038/onc.2011.193.
   PubMed Web of Science ®Google Scholar
• Wang P, Ren Z, Sun P. 2012. Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation. J Cell Biochem 113:1868–1874. https://doi.org/10.1002/jcb.24055.
   PubMed Web of Science ®Google Scholar
• Zhang X, Rice K, Wang Y, Chen W, Zhong Y, Nakayama Y, Zhou Y, Klibanski A. 2010. Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions. Endocrinology 151:939–947. https://doi.org/10.1210/en.2009-0657.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhou Y, Klibanski A. 2010. Isolation and characterization of novel pituitary tumor related genes: a cDNA representational difference approach. Mol Cell Endocrinol 326:40–47. https://doi.org/10.1016/j.mce.2010.02.040.
   PubMedGoogle Scholar
• Zhang X, Zhou Y, Mehta KR, Danila DC, Scolavino S, Johnson SR, Klibanski A. 2003. A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab 88:5119–5126. https://doi.org/10.1210/jc.2003-030222.
   PubMed Web of Science ®Google Scholar
• Hughes CM, Rozenblatt-Rosen O, Milne TA, Copeland TD, Levine SS, Lee JC, Hayes DN, Shanmugam KS, Bhattacharjee A, Biondi CA, Kay GF, Hayward NK, Hess JL, Meyerson M. 2004. Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol Cell 13:587–597. https://doi.org/10.1016/S1097-2765(04)00081-4.
   PubMed Web of Science ®Google Scholar
• Yokoyama A, Wang Z, Wysocka J, Sanyal M, Aufiero DJ, Kitabayashi I, Herr W, Cleary ML. 2004. Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol Cell Biol 24:5639–5649. https://doi.org/10.1128/MCB.24.13.5639-5649.2004.
   PubMed Web of Science ®Google Scholar
• Hansen KH, Helin K. 2009. Epigenetic inheritance through self-recruitment of the polycomb repressive complex 2. Epigenetics 4:133–138. https://doi.org/10.4161/epi.4.3.8483.
   PubMed Web of Science ®Google Scholar
• Margueron R, Reinberg D. 2011. The Polycomb complex PRC2 and its mark in life. Nature 469:343–349. https://doi.org/10.1038/nature09784.
   PubMed Web of Science ®Google Scholar
• Chu C, Qu K, Zhong FL, Artandi SE, Chang HY. 2011. Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Mol Cell 44:667–678. https://doi.org/10.1016/j.molcel.2011.08.027.
   PubMed Web of Science ®Google Scholar
• Martianov I, Ramadass A, Serra Barros A, Chow N, Akoulitchev A. 2007. Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature 445:666–670. https://doi.org/10.1038/nature05519.
   PubMed Web of Science ®Google Scholar
• Chu C, Chang HY. 2016. Understanding RNA-chromatin interactions using chromatin isolation by RNA purification (ChIRP). Methods Mol Biol 1480:115–123. https://doi.org/10.1007/978-1-4939-6380-5_10.
   PubMedGoogle Scholar
• Gupta RM, Hadaya J, Trehan A, Zekavat SM, Roselli C, Klarin D, Emdin CA, Hilvering CRE, Bianchi V, Mueller C, Khera AV, Ryan RJH, Engreitz JM, Issner R, Shoresh N, Epstein CB, de Laat W, Brown JD, Schnabel RB, Bernstein BE, Kathiresan S. 2017. A genetic variant associated with five vascular diseases is a distal regulator of endothelin-1 gene expression. Cell 170:522–533. https://doi.org/10.1016/j.cell.2017.06.049.
   PubMed Web of Science ®Google Scholar
• Webster DE, Barajas B, Bussat RT, Yan KJ, Neela PH, Flockhart RJ, Kovalski J, Zehnder A, Khavari PA. 2014. Enhancer-targeted genome editing selectively blocks innate resistance to oncokinase inhibition. Genome Res 24:751–760. https://doi.org/10.1101/gr.166231.113.
   PubMedGoogle Scholar
• Kaneko S, Son J, Shen SS, Reinberg D, Bonasio R. 2013. PRC2 binds active promoters and contacts nascent RNAs in embryonic stem cells. Nat Struct Mol Biol 20:1258–1264. https://doi.org/10.1038/nsmb.2700.
   PubMed Web of Science ®Google Scholar
• Verma SK, Tian X, LaFrance LV, Duquenne C, Suarez DP, Newlander KA, Romeril SP, Burgess JL, Grant SW, Brackley JA, Graves AP, Scherzer DA, Shu A, Thompson C, Ott HM, Aller GS, Machutta CA, Diaz E, Jiang Y, Johnson NW, Knight SD, Kruger RG, McCabe MT, Dhanak D, Tummino PJ, Creasy CL, Miller WH. 2012. Identification of potent, selective, cell-active inhibitors of the histone lysine methyltransferase EZH2. ACS Med Chem Lett 3:1091–1096. https://doi.org/10.1021/ml3003346.
   PubMed Web of Science ®Google Scholar
• Liu F, Somarowthu S, Pyle AM. 2017. Visualizing the secondary and tertiary architectural domains of lncRNA RepA. Nat Chem Biol 13:282–289. https://doi.org/10.1038/nchembio.2272.
   PubMed Web of Science ®Google Scholar
• Mondal T, Subhash S, Vaid R, Enroth S, Uday S, Reinius B, Mitra S, Mohammed A, James AR, Hoberg E, Moustakas A, Gyllensten U, Jones SJ, Gustafsson CM, Sims AH, Westerlund F, Gorab E, Kanduri C. 2015. MEG3 long noncoding RNA regulates the TGF-beta pathway genes through formation of RNA-DNA triplex structures. Nat Commun 6:7743. https://doi.org/10.1038/ncomms8743.
   PubMed Web of Science ®Google Scholar
• Vance KW, Ponting CP. 2014. Transcriptional regulatory functions of nuclear long noncoding RNAs. Trends Genet 30:348–355. https://doi.org/10.1016/j.tig.2014.06.001.
   PubMed Web of Science ®Google Scholar
• Lin W, Watanabe H, Peng S, Francis JM, Kaplan N, Pedamallu CS, Ramachandran A, Agoston A, Bass AJ, Meyerson M. 2015. Dynamic epigenetic regulation by menin during pancreatic islet tumor formation. Mol Cancer Res 13:689–698. https://doi.org/10.1158/1541-7786.MCR-14-0457.
   PubMed Web of Science ®Google Scholar
• Lines KE, Stevenson M, Filippakopoulos P, Muller S, Lockstone HE, Wright B, Grozinsky-Glasberg S, Grossman AB, Knapp S, Buck D, Bountra C, Thakker RV. 2017. Epigenetic pathway inhibitors represent potential drugs for treating pancreatic and bronchial neuroendocrine tumors. Oncogenesis 6:e332. https://doi.org/10.1038/oncsis.2017.30.
   PubMedGoogle Scholar
• Dreijerink KM, Groner AC, Vos ES, Font-Tello A, Gu L, Chi D, Reyes J, Cook J, Lim E, Lin CY, de Laat W, Rao PK, Long HW, Brown M. 2017. Enhancer-mediated oncogenic function of the menin tumor suppressor in breast cancer. Cell Rep 18:2359–2372. https://doi.org/10.1016/j.celrep.2017.02.025.
   PubMedGoogle Scholar
• Kaneko S, Bonasio R, Saldana-Meyer R, Yoshida T, Son J, Nishino K, Umezawa A, Reinberg D. 2014. Interactions between JARID2 and noncoding RNAs regulate PRC2 recruitment to chromatin. Mol Cell 53:290–300. https://doi.org/10.1016/j.molcel.2013.11.012.
   PubMed Web of Science ®Google Scholar
• Alvarez-Perez JC, Ernst S, Demirci C, Casinelli GP, Mellado-Gil JM, Rausell-Palamos F, Vasavada RC, Garcia-Ocana A. 2014. Hepatocyte growth factor/c-Met signaling is required for beta-cell regeneration. Diabetes 63:216–223. https://doi.org/10.2337/db13-0333.
   PubMed Web of Science ®Google Scholar
• Mellado-Gil J, Rosa TC, Demirci C, Gonzalez-Pertusa JA, Velazquez-Garcia S, Ernst S, Valle S, Vasavada RC, Stewart AF, Alonso LC, Garcia-Ocana A. 2011. Disruption of hepatocyte growth factor/c-Met signaling enhances pancreatic beta-cell death and accelerates the onset of diabetes. Diabetes 60:525–536. https://doi.org/10.2337/db09-1305.
   PubMedGoogle Scholar
• Roccisana J, Reddy V, Vasavada RC, Gonzalez-Pertusa JA, Magnuson MA, Garcia-Ocana A. 2005. Targeted inactivation of hepatocyte growth factor receptor c-met in beta-cells leads to defective insulin secretion and GLUT-2 downregulation without alteration of beta-cell mass. Diabetes 54:2090–2102. https://doi.org/10.2337/diabetes.54.7.2090.
   PubMedGoogle Scholar
• Sun B, Liu R, Xiao ZD. 24April2015. Induction of insulin-producing cells from umbilical cord blood-derived stromal cells by activation of the c-Met/HGF axis. Dev Growth Differ https://doi.org/10.1111/dgd.12214.
   Google Scholar
• Desai SS, Kharade SS, Parekh VI, Iyer S, Agarwal SK. 2015. Pro-oncogenic roles of HLXB9 protein in insulinoma cells through interaction with Nono protein and down-regulation of the c-Met inhibitor Cblb (Casitas B-lineage lymphoma b). J Biol Chem 290:25595–25608. https://doi.org/10.1074/jbc.M115.661413.
   PubMedGoogle Scholar
• Desai SS, Modali SD, Parekh VI, Kebebew E, Agarwal SK. 2014. GSK-3beta protein phosphorylates and stabilizes HLXB9 protein in insulinoma cells to form a targetable mechanism of controlling insulinoma cell proliferation. J Biol Chem 289:5386–5398. https://doi.org/10.1074/jbc.M113.533612.
   PubMedGoogle Scholar
• Miyazaki J, Araki K, Yamato E, Ikegami H, Asano T, Shibasaki Y, Oka Y, Yamamura K. 1990. Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127:126–132. https://doi.org/10.1210/endo-127-1-126.
   PubMed Web of Science ®Google Scholar
• Shi K, Parekh VI, Roy S, Desai SS, Agarwal SK. 2013. The embryonic transcription factor Hlxb9 is a menin interacting partner that controls pancreatic beta-cell proliferation and the expression of insulin regulators. Endocr Relat Cancer 20:111–122. https://doi.org/10.1530/ERC-12-0077.
   PubMed Web of Science ®Google Scholar
• Chu C, Quinn J, Chang HY. 25March2012. Chromatin isolation by RNA purification (ChIRP). J Vis Exp https://doi.org/10.3791/3912.
   Google Scholar
• Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45. https://doi.org/10.1093/nar/29.9.e45.
   PubMed Web of Science ®Google Scholar
• Buske FA, Bauer DC, Mattick JS, Bailey TL. 2012. Triplexator: detecting nucleic acid triple helices in genomic and transcriptomic data. Genome Res 22:1372–1381. https://doi.org/10.1101/gr.130237.111.
   PubMed Web of Science ®Google Scholar
• Buske FA, Bauer DC, Mattick JS, Bailey TL. 2013. Triplex-Inspector: an analysis tool for triplex-mediated targeting of genomic loci. Bioinformatics 29:1895–1897. https://doi.org/10.1093/bioinformatics/btt315.
   PubMedGoogle Scholar